Who Paid My Doc
William Baumgartl
Interventional Pain Medicine Antioch, CA Medical Doctor
NPI 1528004496 CMS profile 205019
2245 Cordoba Way, Antioch, CA 94509
General payments
$12,900
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, William Baumgartl of Antioch, CA is reported in the CMS Open Payments database as having received $12,900 across 389 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 78th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $789 | 25 | |
| 2024 | General | $2,063 | 54 | |
| 2023 | General | $2,073 | 34 | |
| 2022 | General | $1,548 | 41 | |
| 2021 | General | $2,970 | 86 | |
| 2020 | General | $1,153 | 77 | |
| 2019 | General | $2,304 | 72 |
Beside peers
- William Baumgartl
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to William Baumgartl were reported at $789. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | William Baumgartl | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,304 | $684 | $216–$2,079 | $163 |
| 2020 | $1,153 | $382 | $122–$1,109 | $114 |
| 2021 | $2,970 | $552 | $167–$1,554 | $132 |
| 2022 | $1,548 | $605 | $187–$1,924 | $149 |
| 2023 | $2,073 | $671 | $195–$1,915 | $160 |
| 2024 | $2,063 | $684 | $206–$1,837 | $164 |
| 2025 | $789 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 23 drugsPart D claims
1,117
Drug cost
$45,708
Branded share of claims
41.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 22 | $20,864 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 317 | $10,233 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 109 | $4,734 | |
| Zonisamide | Generic | 64 | $2,109 | |
| Tizanidine Hcl | Generic | 109 | $1,072 | |
| Gabapentin | Generic | 75 | $1,044 | |
| Lidocaine | Generic | 11 | $747 | |
| Baclofen | Generic | 22 | $708 | |
| Pregabalin | Generic | 47 | $685 | |
| Oxycodone Hcl | Generic | 42 | $614 |
The 10 drugs with the highest cost, of 23 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,476 Part D prescribers listed as Interventional Pain Management; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 42 billing codesPaid by Medicare
$65,432
Medicare patients
152
Services billed
555
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 38% | |
| Depression | 33% | |
| Ischemic heart disease | 30% | |
| Chronic kidney disease | 26% | |
| COPD | 25% | |
| Heart failure | 19% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
389 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in California
Michael Verdolin
Interventional Pain Medicine · La Mesa, CA
Tim Leier
Interventional Pain Medicine · Rancho Mirage, CA
Jonathan Grossman
Interventional Pain Medicine · Visalia, CA
Kasra Maasumi
Interventional Pain Medicine · Rancho Santa Margarita, CA
Andrew Germanovich
Interventional Pain Medicine · Rancho Mirage, CA
David Lee
Interventional Pain Medicine · Yorba Linda, CA
Related records
Interventional Pain Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.